✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Procter & Gamble Health Ltd.

PGHL

Market Cap
₹9,830 Cr.
P/E
39.14

Procter & Gamble Health Ltd.

  • Procter&Gamble Healt
  • Strides Pharma Scien
  • Marksans Pharma
FAQs on Procter & Gamble Health Ltd. Shareprice

Procter&Gamble Healt has given better returns compared to its competitors.
Procter&Gamble Healt has grown at ~22.14% over the last 10yrs while peers have grown at a median rate of 6.83%

Procter&Gamble Healt is not expensive.
Latest PE of Procter&Gamble Healt is 39.14, while 3 year average PE is 41.11.
Also latest EV/EBITDA of Procter&Gamble Healt is 26.3 while 3yr average is 28.14.

View FAQ's On Business
Growth Table
  • Procter & Gamble Health Ltd.
  • Strides Pharma Scien
  • Marksans Pharma
Balance Sheet
  • Procter & Gamble Health Ltd.
  • Strides Pharma Scien
  • Marksans Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Procter & Gamble Health Ltd.
  • Strides Pharma Scien
  • Marksans Pharma
Cash Flow
  • Procter & Gamble Health Ltd.
  • Strides Pharma Scien
  • Marksans Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Procter & Gamble Health Ltd.
  • Strides Pharma Scien
  • Marksans Pharma
Quarterly Results
  • Procter & Gamble Health Ltd.
  • Strides Pharma Scien
  • Marksans Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Procter & Gamble Health Ltd. Financials

Balance sheet of Procter&Gamble Healt is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Procter&Gamble Healt is increasing.
Latest net debt of Procter&Gamble Healt is -₹188.55 Crs as of Mar-25.
This is greater than Jun-24 when it was -₹488.72 Crs.

The profit is oscillating.
The profit of Procter&Gamble Healt is ₹251 Crs for TTM, ₹201 Crs for Jun 2024 and ₹229 Crs for Jun 2023.

The company seems to pay a good stable dividend.
Procter&Gamble Healt latest dividend payout ratio is 214.75% and 3yr average dividend payout ratio is 109.58%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech